HK Stock MarketDetailed Quotes

02315 BIOCYTOGEN-B

Watchlist

5.830
+0.100+1.75%

Trading Nov 28 15:31 CST

2.33BMarket Cap-8714P/E (TTM)

BIOCYTOGEN-B Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q6)Jun 30, 2024

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(Q6)Jun 30, 2022

(FY)Dec 31, 2021

(FY)Dec 31, 2020

(FY)Dec 31, 2019

Assets

Current assets

Inventory

-67.70%4.64M

-60.14%7.42M

-47.20%14.35M

22.88%18.6M

--27.18M

89.72%15.14M

159.68%7.98M

--3.07M

Accounts receivable

60.99%184.63M

32.23%142.38M

15.79%114.68M

4.46%107.68M

--99.04M

53.35%103.09M

85.49%67.23M

--36.24M

Advance deposits and other receivables

-22.03%24.72M

-35.39%26.06M

-66.08%31.71M

-49.35%40.33M

--93.46M

66.83%79.62M

118.94%47.73M

--21.8M

Cash and equivalents

-25.38%411.24M

-33.35%417.66M

58.82%551.09M

34.34%626.62M

--347M

-37.81%466.45M

204.42%750.04M

--246.38M

Special items of current assets

4.91%132.31M

2.71%121.05M

1.70%126.11M

7.20%117.86M

--124M

47.26%109.94M

43.13%74.66M

--52.16M

Total current assets

-9.49%766.14M

-21.35%723.05M

22.56%846.52M

5.15%919.3M

--690.68M

-23.82%874.24M

70.87%1.15B

--671.64M

Non-current assets

Property, plant and equipment

-12.36%1.39B

-9.27%1.45B

10.23%1.59B

14.96%1.6B

--1.44B

22.49%1.39B

112.88%1.14B

--533.45M

Associated company interest

-7.30%179.29M

-4.83%188.38M

28,095.19%193.42M

1,943.82%197.94M

--686K

-3.99%9.69M

--10.09M

----

Intangible assets

-23.54%24.44M

-8.23%28.13M

457.15%31.97M

406.23%30.65M

--5.74M

149.38%6.06M

15.07%2.43M

--2.11M

Other illiquid assets

24.12%67.45M

11.66%59.03M

61.55%54.34M

141.82%52.86M

--33.64M

-28.97%21.86M

101.77%30.77M

--15.25M

Total non-current assets

-10.97%1.67B

-8.20%1.73B

26.11%1.87B

31.64%1.88B

--1.48B

21.18%1.43B

114.03%1.18B

--550.81M

Total assets

-10.51%2.43B

-12.52%2.45B

24.98%2.72B

21.58%2.8B

--2.17B

-1.02%2.3B

90.32%2.33B

--1.22B

Liabilities

Current liabilities

Accounts payable

-5.69%117.78M

19.87%175.23M

2.94%124.88M

42.71%146.19M

--121.32M

16.94%102.44M

399.77%87.6M

--17.53M

Tax payable

71.00%2.09M

33.33%1.07M

--1.22M

--804K

----

Other payables and accrued expenses

-37.42%132.85M

-44.22%128.89M

-8.83%212.29M

-9.61%231.07M

--232.86M

42.62%255.64M

98.24%179.25M

--90.42M

Bank loans and overdrafts

22.69%223.61M

39.61%176.84M

218.19%182.26M

--126.67M

--57.28M

----

Financial lease liabilities-current liabilities

-51.45%23.08M

-41.33%26.36M

59.80%47.54M

67.07%44.94M

--29.75M

90.68%26.9M

500.00%14.11M

--2.35M

Special items of current liabilities

----

--1.26B

Total current liabilities

-11.85%572.61M

-4.69%577.62M

18.98%649.56M

35.71%606.05M

--545.95M

35.95%446.56M

-76.70%328.47M

--1.41B

Net current assets

-1.74%193.54M

-53.57%145.43M

36.08%196.96M

-26.76%313.25M

--144.73M

-47.79%427.68M

210.97%819.17M

---738.21M

Total assets less current liabilities

-10.09%1.86B

-14.68%1.87B

27.00%2.07B

18.19%2.19B

--1.63B

-7.10%1.86B

1,166.16%2B

---187.41M

Non-current liabilities

Long-term bank loan

227.31%171.87M

233.34%173.91M

--52.51M

--52.17M

----

Long-term accounts payable

-9.78%699.69M

-8.16%651.48M

60.87%775.53M

58.14%709.36M

--482.07M

17.15%448.55M

73.40%382.88M

--220.81M

Financial lease liabilities-non-current liabilities

-16.11%156.69M

-12.79%167.01M

226.13%186.78M

204.45%191.51M

--57.27M

-5.85%62.9M

1,053.92%66.81M

--5.79M

Deferred tax liability

--1.41M

--1.9M

----

Deferred income-non-current liabilities

-3.14%85.72M

-3.18%87.07M

-3.13%88.5M

-3.09%89.93M

--91.37M

2.97%92.8M

-1.07%90.12M

--91.1M

Total non-current liabilities

1.09%1.12B

3.68%1.08B

74.93%1.1B

72.60%1.04B

--630.71M

11.94%604.25M

69.91%539.81M

--317.7M

Total liabilities

-3.70%1.69B

0.60%1.66B

48.97%1.75B

56.93%1.65B

--1.18B

21.02%1.05B

-49.74%868.28M

--1.73B

Total assets less total liabilities

-22.87%744.24M

-31.32%790.44M

-3.30%964.91M

-8.08%1.15B

--997.86M

-14.15%1.25B

388.70%1.46B

---505.11M

Total equity and non-current liabilities

-10.09%1.86B

-14.68%1.87B

27.00%2.07B

18.19%2.19B

--1.63B

-7.10%1.86B

1,166.16%2B

---187.41M

Equity

Share capital

0.00%399.4M

6.53%399.4M

--374.93M

4.15%374.93M

886.30%360M

--36.5M

Reserve

-39.34%340.29M

-48.25%386.49M

-9.29%560.96M

-14.38%746.87M

--618.38M

-20.22%872.28M

371.67%1.09B

---402.48M

Shareholders' Equity

-22.98%739.69M

-31.44%785.89M

-3.32%960.36M

-8.09%1.15B

--993.31M

-14.19%1.25B

497.13%1.45B

---365.98M

Non-controlling interest

0.00%4.55M

-0.02%4.55M

-0.11%4.55M

-4.45%4.55M

--4.56M

-1.39%4.76M

103.47%4.83M

---139.13M

Total equity

-22.87%744.24M

-31.32%790.44M

-3.30%964.91M

-8.08%1.15B

--997.86M

-14.15%1.25B

388.70%1.46B

---505.11M

Total equity and total liabilities

-10.51%2.43B

-12.52%2.45B

24.98%2.72B

21.58%2.8B

--2.17B

-1.02%2.3B

90.32%2.33B

--1.22B

Currency Unit

CNY

Accounting Standards

IAS

Audit Opinions

Unqualified Opinion

Auditor

KPMG

	(Q6)Jun 30, 2024	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(Q6)Jun 30, 2022	(FY)Dec 31, 2021	(FY)Dec 31, 2020	(FY)Dec 31, 2019
Assets
Current assets
Inventory	-67.70%4.64M	-60.14%7.42M	-47.20%14.35M	22.88%18.6M	--27.18M	89.72%15.14M	159.68%7.98M	--3.07M
Accounts receivable	60.99%184.63M	32.23%142.38M	15.79%114.68M	4.46%107.68M	--99.04M	53.35%103.09M	85.49%67.23M	--36.24M
Advance deposits and other receivables	-22.03%24.72M	-35.39%26.06M	-66.08%31.71M	-49.35%40.33M	--93.46M	66.83%79.62M	118.94%47.73M	--21.8M
Cash and equivalents	-25.38%411.24M	-33.35%417.66M	58.82%551.09M	34.34%626.62M	--347M	-37.81%466.45M	204.42%750.04M	--246.38M
Special items of current assets	4.91%132.31M	2.71%121.05M	1.70%126.11M	7.20%117.86M	--124M	47.26%109.94M	43.13%74.66M	--52.16M
Total current assets	-9.49%766.14M	-21.35%723.05M	22.56%846.52M	5.15%919.3M	--690.68M	-23.82%874.24M	70.87%1.15B	--671.64M
Non-current assets
Property, plant and equipment	-12.36%1.39B	-9.27%1.45B	10.23%1.59B	14.96%1.6B	--1.44B	22.49%1.39B	112.88%1.14B	--533.45M
Associated company interest	-7.30%179.29M	-4.83%188.38M	28,095.19%193.42M	1,943.82%197.94M	--686K	-3.99%9.69M	--10.09M	----
Intangible assets	-23.54%24.44M	-8.23%28.13M	457.15%31.97M	406.23%30.65M	--5.74M	149.38%6.06M	15.07%2.43M	--2.11M
Other illiquid assets	24.12%67.45M	11.66%59.03M	61.55%54.34M	141.82%52.86M	--33.64M	-28.97%21.86M	101.77%30.77M	--15.25M
Total non-current assets	-10.97%1.67B	-8.20%1.73B	26.11%1.87B	31.64%1.88B	--1.48B	21.18%1.43B	114.03%1.18B	--550.81M
Total assets	-10.51%2.43B	-12.52%2.45B	24.98%2.72B	21.58%2.8B	--2.17B	-1.02%2.3B	90.32%2.33B	--1.22B
Liabilities
Current liabilities
Accounts payable	-5.69%117.78M	19.87%175.23M	2.94%124.88M	42.71%146.19M	--121.32M	16.94%102.44M	399.77%87.6M	--17.53M
Tax payable	71.00%2.09M	33.33%1.07M	--1.22M	--804K	----	----	----	----
Other payables and accrued expenses	-37.42%132.85M	-44.22%128.89M	-8.83%212.29M	-9.61%231.07M	--232.86M	42.62%255.64M	98.24%179.25M	--90.42M
Bank loans and overdrafts	22.69%223.61M	39.61%176.84M	218.19%182.26M	--126.67M	--57.28M	----	----	----
Financial lease liabilities-current liabilities	-51.45%23.08M	-41.33%26.36M	59.80%47.54M	67.07%44.94M	--29.75M	90.68%26.9M	500.00%14.11M	--2.35M
Special items of current liabilities	----	----	----	----	----	----	----	--1.26B
Total current liabilities	-11.85%572.61M	-4.69%577.62M	18.98%649.56M	35.71%606.05M	--545.95M	35.95%446.56M	-76.70%328.47M	--1.41B
Net current assets	-1.74%193.54M	-53.57%145.43M	36.08%196.96M	-26.76%313.25M	--144.73M	-47.79%427.68M	210.97%819.17M	---738.21M
Total assets less current liabilities	-10.09%1.86B	-14.68%1.87B	27.00%2.07B	18.19%2.19B	--1.63B	-7.10%1.86B	1,166.16%2B	---187.41M
Non-current liabilities
Long-term bank loan	227.31%171.87M	233.34%173.91M	--52.51M	--52.17M	----	----	----	----
Long-term accounts payable	-9.78%699.69M	-8.16%651.48M	60.87%775.53M	58.14%709.36M	--482.07M	17.15%448.55M	73.40%382.88M	--220.81M
Financial lease liabilities-non-current liabilities	-16.11%156.69M	-12.79%167.01M	226.13%186.78M	204.45%191.51M	--57.27M	-5.85%62.9M	1,053.92%66.81M	--5.79M
Deferred tax liability	--1.41M	--1.9M	----	----	----	----	----	----
Deferred income-non-current liabilities	-3.14%85.72M	-3.18%87.07M	-3.13%88.5M	-3.09%89.93M	--91.37M	2.97%92.8M	-1.07%90.12M	--91.1M
Total non-current liabilities	1.09%1.12B	3.68%1.08B	74.93%1.1B	72.60%1.04B	--630.71M	11.94%604.25M	69.91%539.81M	--317.7M
Total liabilities	-3.70%1.69B	0.60%1.66B	48.97%1.75B	56.93%1.65B	--1.18B	21.02%1.05B	-49.74%868.28M	--1.73B
Total assets less total liabilities	-22.87%744.24M	-31.32%790.44M	-3.30%964.91M	-8.08%1.15B	--997.86M	-14.15%1.25B	388.70%1.46B	---505.11M
Total equity and non-current liabilities	-10.09%1.86B	-14.68%1.87B	27.00%2.07B	18.19%2.19B	--1.63B	-7.10%1.86B	1,166.16%2B	---187.41M
Equity
Share capital	0.00%399.4M	0.00%399.4M	6.53%399.4M	6.53%399.4M	--374.93M	4.15%374.93M	886.30%360M	--36.5M
Reserve	-39.34%340.29M	-48.25%386.49M	-9.29%560.96M	-14.38%746.87M	--618.38M	-20.22%872.28M	371.67%1.09B	---402.48M
Shareholders' Equity	-22.98%739.69M	-31.44%785.89M	-3.32%960.36M	-8.09%1.15B	--993.31M	-14.19%1.25B	497.13%1.45B	---365.98M
Non-controlling interest	0.00%4.55M	-0.02%4.55M	-0.11%4.55M	-4.45%4.55M	--4.56M	-1.39%4.76M	103.47%4.83M	---139.13M
Total equity	-22.87%744.24M	-31.32%790.44M	-3.30%964.91M	-8.08%1.15B	--997.86M	-14.15%1.25B	388.70%1.46B	---505.11M
Total equity and total liabilities	-10.51%2.43B	-12.52%2.45B	24.98%2.72B	21.58%2.8B	--2.17B	-1.02%2.3B	90.32%2.33B	--1.22B
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS
Audit Opinions	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	Unqualified Opinion	Unqualified Opinion
Auditor	--	KPMG	--	KPMG	--	KPMG	KPMG	KPMG

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

02315 BIOCYTOGEN-B

BIOCYTOGEN-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Analysis

Analyst Rating

Price Target